8-K: Health Catalyst Secures $225 Million Credit Facility to Refinance Debt and Fund Growth

Health Catalyst has entered into a five-year term loan agreement for up to $225 million to refinance existing debt and support future growth initiatives.

Summary

• Health Catalyst has secured a $225 million credit facility with Silver Point Finance.
• The facility includes an initial $125 million term loan, which was fully drawn on July 16, 2024, and a $100 million delayed draw term loan facility.
• The initial loan proceeds will be used to refinance existing convertible notes due in 2025 and for general corporate purposes.
• The delayed draw facility can be accessed in two tranches: up to $40 million within six months of the closing date and an additional $60 million within 18 months, subject to certain conditions.
• The delayed draw funds are intended to support the company's inorganic growth strategy, including acquisitions.
• The term loans mature on July 16, 2029, and interest rates are based on either a base rate plus 5.50% or SOFR plus 6.50%, with floors of 2.00% and 1.00% respectively.
• The company will also pay commitment fees on the undrawn portion of the delayed draw facility, ranging from 1.50% to 2.50% per annum.
• The loan agreement includes mandatory prepayment requirements under certain conditions, such as excess cash flow or asset sales, and voluntary prepayments are subject to premiums that decrease over time.
• The agreement also includes financial covenants, such as minimum liquidity and maximum leverage ratios, and is secured by substantially all of the company's assets.

Sentiment

Score: 8

Explanation: The document conveys a positive sentiment due to the successful securing of a significant credit facility, which is expected to support the company's growth and financial stability. The management's comments are also optimistic, further boosting the positive outlook.

Positives

• The credit facility provides Health Catalyst with non-dilutive capital to refinance existing convertible notes.
• The delayed draw feature offers flexibility to pursue acquisitions and inorganic growth opportunities.
• The financing allows the company to maintain a strong and flexible balance sheet.
• The partnership with Silver Point Finance is seen as a long-term strategic advantage.
• The company believes the financing structure enables them to focus on creating value for shareholders.

Negatives

• The company is subject to financial covenants, including minimum liquidity and maximum leverage ratios.
• Mandatory prepayments are required under certain conditions, which could limit financial flexibility.
• Voluntary prepayments are subject to premiums, which could increase the cost of refinancing.
• The company is subject to interest rate risk, as rates are based on base rate or SOFR plus a margin.
• The credit agreement includes restrictions on the company's ability to take certain actions, such as incurring debt or selling assets.

Risks

• The company's ability to draw on the delayed draw facility is subject to meeting certain conditions.
• Fluctuations in interest rates could increase the cost of borrowing.
• Failure to comply with financial covenants could trigger an event of default.
• The company's ability to execute its acquisition strategy depends on the availability of the delayed draw funds.
• The company's financial performance must meet expectations to avoid mandatory prepayments.

Future Outlook

The company intends to use the credit facility to refinance existing debt, pursue acquisitions, and fund growth initiatives. They believe the financing provides flexibility and supports their long-term strategy.

Management Comments

• Dan Burton, Health Catalyst's CEO, stated that the credit facility assists with refinancing existing convertible notes and provides flexibility for growth opportunities.
• Jason Alger, Health Catalyst's CFO, noted that the financing is a dynamic, flexible solution that allows the company to refinance debt and fund growth in a non-dilutive way.
• Anthony DiNello, Head of Silver Point Finance, expressed confidence in Health Catalyst's team and strategy, stating that their capital provides the time and flexibility to execute their plan.

Industry Context

This announcement is consistent with the trend of healthcare technology companies seeking capital to fund growth and acquisitions. The credit facility provides Health Catalyst with a competitive advantage by enabling them to pursue strategic opportunities.

Comparison to Industry Standards

• The use of a term loan facility with a delayed draw feature is a common financing strategy for companies looking to fund acquisitions and growth.
• The interest rates and commitment fees are within the typical range for similar credit facilities in the current market.
• The financial covenants, such as minimum liquidity and maximum leverage ratios, are standard for such agreements.
• Other companies in the healthcare technology space, such as Veeva Systems and Cerner, have also utilized debt financing to support their growth strategies.
• The size of the credit facility is appropriate for a company of Health Catalyst's size and growth trajectory.

Stakeholder Impact

• Shareholders are expected to benefit from the company's ability to refinance debt and pursue growth opportunities.
• Employees may see increased job security and opportunities as the company expands.
• Customers may benefit from the company's ability to invest in technology and services.
• Creditors are secured by the company's assets and are expected to receive timely payments.
• Suppliers may see increased business opportunities as the company grows.

Next Steps

• Health Catalyst will use the initial term loan to refinance existing convertible notes.
• The company will continue to evaluate acquisition opportunities to utilize the delayed draw facility.
• Health Catalyst will monitor its financial performance to ensure compliance with the financial covenants.
• The company will make quarterly amortization and commitment fee payments as required by the agreement.

Key Dates

Keywords

Credit Facility, Term Loan, Debt Financing, Refinancing, Acquisition, Inorganic Growth, Convertible Notes, Silver Point Finance, Healthcare Analytics, Financial Covenants